Get the Stockscreener App
1.42
6.58%
-0.10
Lava Therapeutics Nv stock is traded at $1.42, with a volume of 38,919.
It is down -6.58% in the last 24 hours and up +7.58% over the past month.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.
See More
Previous Close:
$1.52
Open:
$1.48
24h Volume:
38,919
Relative Volume:
1.01
Market Cap:
$37.35M
Revenue:
$9.06M
Net Income/Loss:
$-50.39M
P/E Ratio:
-0.7396
EPS:
-1.92
Net Cash Flow:
$5.89M
1W Performance:
-0.70%
1M Performance:
+7.58%
6M Performance:
+44.90%
1Y Performance:
-31.07%
1-Day Range:
$1.41
$1.48
1-Week Range:
$1.34
$1.69
52-Week Range:
$0.8502
$2.093
Lava Therapeutics Nv Stock (LVTX) Company Profile
Name
Lava Therapeutics Nv
Sector
Industry
Phone
31 6 3000 3035
Address
YALELAAN 62, UTRECHT
Compare LVTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LVTX
Lava Therapeutics Nv
|
1.42 | 39.98M | 9.06M | -50.39M | 5.89M | -1.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Lava Therapeutics Nv Stock (LVTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-12-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Dec-11-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Oct-25-22 | Initiated | H.C. Wainwright | Buy |
| Apr-19-21 | Initiated | JP Morgan | Overweight |
| Apr-19-21 | Initiated | Jefferies | Buy |
| Apr-19-21 | Initiated | SVB Leerink | Outperform |
View All
Lava Therapeutics Nv Stock (LVTX) Latest News
Live market analysis of LAVA Therapeutics N.V.Free Market Surge Signal for Swing Traders - Newser
What earnings revisions data tells us about LAVA Therapeutics N.V.Intelligent Trade Forecast With AI Analytics - Newser
What makes LAVA Therapeutics N.V. stock price move sharplyAlgorithmic Prediction of Market Breakouts - Newser
What catalysts could drive LAVA Therapeutics N.V. stock higher in 2025Smart Portfolio Outlook For Consistent Profits - jammulinksnews.com
Lava Therapeutics’ LAVA-1207 Study Terminated: Implications for Investors - TipRanks
LAVA Therapeutics N.V. stock momentum explainedStock Trading Session Highlights and Summary - Newser
Real time social sentiment graph for LAVA Therapeutics N.V.Predictive AI Signals for Short-Term Trading - Newser
Can a trend reversal in LAVA Therapeutics N.V. lead to recoveryAI Screener Based Stock Summary Report - Newser
Why LAVA Therapeutics N.V. stock attracts strong analyst attentionSwing Candidate List with Trade Cues - Newser
When is LAVA Therapeutics N.V. stock expected to show significant growthStock Strategy Signals For Smart Trading - jammulinksnews.com
LAVA Therapeutics N.V. Hits Price Floor — Bounce IncomingBuy Low Sell High Stock Watch Strategy in Focus - metal.it
Technical Heatmap Flags LAVA Therapeutics N.V. for WatchAccurate Buy Point for Momentum Stocks Detected - metal.it
Will breakout in LAVA Therapeutics N.V. lead to full recoveryFree Breakout Entry Signal Confirmation Tool - Newser
Real time breakdown of LAVA Therapeutics N.V. stock performanceHigh Return Strategy with Low Risk - Newser
LAVA Therapeutics N.V. Recovery Hinges on Volume BreakoutSmart Trade Plans With Risk Protection Explained - metal.it
Applying sector rotation models to LAVA Therapeutics N.V.Safe Momentum Strategy With Trend Analysis - Newser
Is LAVA Therapeutics N.V. Stock a Good Fit for Conservative InvestorsHigh Conviction Stock Long-Term Summary - Newser
How Resilient Is LAVA Therapeutics N.V. Stock During Economic DownturnsLow Risk Stock Selection Strategy Guide - Newser
What is the risk reward ratio of investing in LAVA Therapeutics N.V. stockPost Market Watchlist For Every Investor - jammulinksnews.com
Recovery Signals Appearing in LAVA Therapeutics N.V. ChartsFast Gaining Stock Screener Reports Released - metal.it
How many analysts rate LAVA Therapeutics N.V. as a “Buy”Build wealth steadily with proven investment techniques - jammulinksnews.com
Key resistance and support levels for LAVA Therapeutics N.V.AI-Based Signal Detection for Active Traders - Newser
Does LAVA Therapeutics N.V. show high probability of reboundFree Stock Market Watch With Alerts - Newser
Is LAVA Therapeutics N.V. Stock a Good Fit for Conservative Investors Free High Yield Stocks With Buy Confirmation - Newser
What are the technical indicators suggesting about LAVA Therapeutics N.V.Free Daily Trading Room Entry - jammulinksnews.com
Is LAVA Therapeutics N.V. stock overvalued or undervaluedSkyrocketing investment returns - jammulinksnews.com
What institutional investors are buying LAVA Therapeutics N.V. stockMassive wealth growth - jammulinksnews.com
What are analysts’ price targets for LAVA Therapeutics N.V. in the next 12 monthsBuild a winning investment strategy today - jammulinksnews.com
Should I hold or sell LAVA Therapeutics N.V. stock in 2025Get real-time alerts on top stocks - jammulinksnews.com
Buy Signal for LAVA Therapeutics N.V. Stock Key Technical Indicators to WatchFree Stock Tips Group - Newser
Lava Therapeutics Nv Stock (LVTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):